
NUVA is a $659.4 million healthcare company that engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. Technically, the breakout that occurred in late January appears to be from a bottoming head & shoulders pattern. Volume was very heavy and you can see the subsequent backtest of that breakout area. On Monday, NUVA hit its 20 day EMA for the first time since breaking out. After trading down the past 6 or 7 trading sessions, this would be an area where we would expect a bounce. We like entry at the current price and again if price support is tested down near $14.75. We’d consider our closing stop to be at $14.50, although the rising 50 day SMA could be used if you’d like to give this one a bit more room. Initial resistance comes in at $17.20, but the measurement on the head & shoulders breakout is $18.50. That’d be our target.
You should consider these educational charts and analysis for possible short-term trades only. We are not registered investment advisors and the following trade setups should not be viewed as investment advice. Accordingly, please check with your financial advisor before deciding to buy or sell any of these investment securities. Read our full Disclaimer below.
Because we do not recommend holding a stock into its earnings report, please check all earnings dates on Charts of the Day stocks before making a decision on whether to consider a trade.








